EU Suspends HIV Drug License
Regulators said Tuesday that they had suspended the marketing authorization for Viracept, an atiretiroviral drug made by Roche and used, as part of a multidrug combination, to treat HIV.
“The suspension follows the contamination of certain batches of Viracept with ethyl mesilate, a genotoxic substance,” the Commission said. “The decision is based on scientific conclusions of the European...
To view the full article, register now.